| Arachidonic Acid |
|
| Product Name |
Product # |
| Arachidonic acid |
A9673 |
| Arachidonic acid Porcine liver, approx. 99 % capillary GC, Oil |
A9673 |
| Arachidonic acid sodium salt Porcine liver, approx. 99 % capillary GC, Powder |
A8798 |
| Anti-inflammatory |
back to top |
| Product Name |
Product # |
| Ketoprofen |
K1751 |
| (S)-(+)-Ketoprofen |
K2135 |
| Loxoprofen |
L0664 |
| Phenylbutazone |
P8386 |
| Sulindac sulfone |
S1438 |
| Enzyme Inhibitors |
back to top |
| Product Name |
Product # |
| Cyclooxygenase |
|
| N-(4-Acetamidophenyl)indomethacinamide |
A1224 |
| Acetylsalicylic acid |
A5376 |
| Diclofenac sodium salt |
D6899 |
| DuP-697 |
D4938 |
| Etodolac |
E0516 |
| FR 122047 hydrochloride > 99% HPLC, powder |
F7553 |
| Ibuprofen |
I4883 |
| (S)-(+)-Ibuprofen Solid |
I-106 |
| Indomethacin heptyl ester solution |
I7904 |
| Ketorolac tris salt |
K1136 |
| Meloxicam |
M3935 |
| Naproxen |
M4015 |
| (-)-Naproxen sodium salt |
M1275 |
| Nimesulide |
N1016 |
| NS-398 Solid |
N-194 |
| N-(2-Phenylethyl)indomethacinamide |
P0740 |
| trans-5-Phenyl-4-pentenyl hydroperoxide |
P6238 |
| Piroxicam |
P5654 |
| N-(3-Pyridyl)indomethacinamide |
P0865 |
| SC-560 |
S2064 |
| Valeryl Salicylate > 98% HPLC |
V2889 |
| Cytochrome P450 |
|
| 1-Aminobenzotriazole |
A3940 |
| 17-Octadecynoic acid |
O8382 |
| 6-(2-Propargyloxyphenyl)hexanoic acid |
P9114 |
| Lipoxygenase |
|
| AA-861 |
A3711 |
| BW A4C minimum 98% HPLC |
B7559 |
| BW B70C > 98% HPLC, solid |
B4558 |
| 5,6-Dehydroarachidonic acid |
D2154 |
| cis-5,8,11,14,17-Eicosapentaenoic acid |
E2011 |
| cis-5,8,11,14,17-Eicosapentaenoic acid sodium salt |
E6627 |
| 5,8,11,14-Eicosatetraynoic acid |
E1768 |
| Meclofenamic acid sodium salt |
M4531 |
| Nordihydroguaiaretic acid from Larrea divaricata (creosote bush) |
N5023 |
| 9,12-Octadecadiynoic acid |
O5636 |
| PD 146176 > 99% HPLC |
P4620 |
| Other |
|
| CAY10397 |
C6734 |
| 9,11-Dideoxy-9a,11a-epoxymethanoprostaglandin F2a |
D0400 |
| Furegrelate sodium salt |
F3764 |
| N-(4-Hydroxyphenyl)-arachidonylamide |
H1911 |
| MK-886 > 98% HPLC |
M2692 |
| Niflumic acid |
N0630 |
| Oleyl trifluoromethyl ketone |
O9887 |
| Ozagrel |
O1385 |
| SC 22716 > 99% HPLC |
P7495 |
| Sesamin |
S9314 |
| Tranilast |
T0318 |
| Enzymes |
back to top |
| Product Name |
Product # |
| Cyclooxygenase 1 from sheep |
C0733 |
| Cyclooxygenase 2 human |
C0858 |
| Lipoxidase preparation from Glycine max (soybean) |
L6632 |
| Lipoxidase preparation from Glycine max (soybean) |
L3004 |
| N-Oleoylglycine |
O9762 |
| Leukotrienes |
back to top |
| Product Name |
Product # |
| Bay u9773 |
B9680 |
| Cinalukast > 99% HPLC |
C6239 |
| 9,11-Dideoxy-11a,9a-epoxymethanoprostaglandin F2a |
D8174 |
| Leukotriene B4 |
L0517 |
| Leukotriene C4 |
L4886 |
| Leukotriene D4 |
L5011 |
| Leukotriene E4 |
L5136 |
| LY-171,883 |
L5408 |
| REV 5901 |
R5523 |
| SR 2640 >= 99% HPLC, solid |
S7690 |
| U-75302 minimum 95.5% HPLC |
U1508 |
| Oxylipins |
back to top |
| Product Name |
Product # |
| 15(S)-Hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid |
H9521 |
| 15S-Hydroxy-5Z,8Z,11Z,13E-eicosatetraene-(2-biotinyl)hydrazide |
H6785 |
| (±)-(6E,8Z,11Z,14Z)-5-Hydroxyeicosatetraenoic acid |
H1017 |
| 8(S)-Hydroxy-(5Z,9E,11Z,14Z)-eicosatetraenoic acid |
H4019 |
| 12(S)-Hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoic acid |
H7768 |
| 15(S)-Hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid |
H1142 |
| 20-Hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoic acid |
H3023 |
| 13S-Hydroxy-9Z,11E-octadecadiene-(2-biotinyl)hydrazide |
H6910 |
| 9[S]-Hydroxy-10E,12Z,15Z-Octadectrienoic acid |
H0661 |
| Stearidonic acid |
S8564 |
| Prostaglandins |
back to top |
| Product Name |
Product # |
| AH13205 min. 98 % (HPLC) oil | A9102 |
| AH23848 min. 99 % | A8227 |
| AH6809 98 % Crystalline solid or supercooled liquid | A1221 |
| AL-8810 >98 % (HPLC) solid | A3846 |
| BM-531 min. 97 % (HPLC) solid | B5806 |
| (R)-Butaprost >99 % (HPLC) | B6309 |
| BW 245C >99 % (HPLC) | B9305 |
| BW A868C | B9180 |
| Daltroban >98 % (HPLC) | D7441 |
| 13,14-Dihydro-15-ketoprostaglandin F2a | D4143 |
| 2,3-Di-nor-8-isoprostaglandin F2a min. 98 % Methyl acetate solution | D4565 |
| Fluprostenol 10 mg/ml in ethanol 98 % | F8549 |
| (+)-Fluprostenol min. 95 % Ethanol solution | F4176 |
| Fluprostenol isopropyl ester >98 % Ethanol solution | F2427 |
| GR 32191B >98 % (HPLC) solid | G5044 |
| L-655,240 min. 98 % (HPLC) | L9539 |
| Latanoprost ³99 % (HPLC) oil | L1167 |
| Latanoprost acid ³99 % (HPLC) | L1292 |
| Limaprost min. 99% crystalline | L6538 |
| Misoprostol free acid min. 90 % | M6932 |
| Misoprostol min. 99 % (TLC) | M6807 |
| ONO-1301 min. 99 % (HPLC) | O2264 |
| 17-Phenyl-tri-norprostaglandin D2 >98 % Methyl acetate solution | P6615 |
| 17-Phenyl-tri-norprostaglandin F2a-ethyl amide min. 95 % solid | P6740 |
| Piriprost potassium salt min. 98 % solid | P6113 |
| Prostaglandin A1 synthetic | P7265 |
| Prostaglandin A2 solution 10 mg/ml in methyl acetate approx. 95 % synthetic | P4547 |
| Prostaglandin B1 synthetic | P5265 |
| Prostaglandin B2 synthetic | P5390 |
| Prostaglandin D2 min. 95 % synthetic | P5172 |
| Prostaglandin E1 min. 98 % (HPLC) synthetic | P5515 |
| Prostaglandin E1 ethyl ester approx. 5 mg/ml in methyl acetate approx. 98 % (HPLC) | P0815 |
| Prostaglandin E1 methyl ester approx. 5 mg/ml in methyl acetate approx. 98 % (HPLC) | P0439 |
| Prostaglandin E2 min. 99 % (TLC) synthetic | P5640 |
| Prostaglandin E2 min. 98 % (TLC) synthetic | P4172 |
| Prostaglandin F1a synthetic | P5765 |
| Prostaglandin F2a tris salt min. 99 % synthetic powder | P0424 |
| Prostaglandin F2a ethanolamide min. 98 % | P6738 |
| Prostaglandin F2a methyl ester approx. 5 mg/ml in methyl acetate min. 98 % (HPLC) | P0314 |
| Prostaglandin H1 >95 % (HPLC) Acetone solution | P6492 |
| Prostaglandin I2 sodium salt min. 96 % (HPLC) synthetic powder | P6188 |
| Prostaglandin J2 approx. 85 % | P9807 |
| SC 19220 min. 99 % (HPLC) solid | S3065 |
| Sulprostone >98 % (HPLC) oil | S8692 |
| Taprostene sodium salt ³98 % (HPLC) | T4949 |
| Thromboxane B2 | T0516 |
| |
back to top |
